Early Tongue Cancer Controversies in management of the neck - PowerPoint PPT Presentation

1 / 31
About This Presentation
Title:

Early Tongue Cancer Controversies in management of the neck

Description:

... facilitate infiltration of neoplastic cells to any area of the neck * * Ca tongue is not a common cancer ... radiation therapy for ... nasopharynx , or skull base ... – PowerPoint PPT presentation

Number of Views:227
Avg rating:3.0/5.0
Slides: 32
Provided by: Sere87
Category:

less

Transcript and Presenter's Notes

Title: Early Tongue Cancer Controversies in management of the neck


1
Early Tongue CancerControversies in management
of the neck
  • Dr. Serena Wong
  • Queen Elizabeth Hospital

2
Introduction
  • Background
  • Current debates in neck management
  • Why is neck treatment so controversial?
  • What are the options for neck treatment?
  • What is the evidence on neck treatment?

3
Background
4
Background
  • Incidence 1.7 per 100000
  • 108 new cases in 2011
  • 0.7 of all new cancer cases
  • 6th leading cancer worldwide
  • 32-40 of all head and neck cancers

HK Cancer registry
5
How early is early?
N0 N1 N2 N3
T1 I
T2 II
T3 III III
T4a IVa IVa IVa
T4b IVb IVb IVb IVb
IVC M1 IVC M1 IVC M1 IVC M1
AJCC Cancer Staging Manual. 7th ed, 2010
6
T staging
Head and Neck Cancer Guide
7
N staging
Head and Neck Cancer Guide
8
N staging
Sensitivity Specificity
Ultrasound 72-80 59-96
CT 78-83 80-96
MRI 50 75
PET-CT 67 85
  • Merritt et al. Arch Otolaryngol Head Neck Surg
    1997 123 149-152
  • Giancarlo et al. Anticancer Res 1998 18 2805-9
  • Akoglu et al. J Otolaryngol 2005 34 384-94
  • Fan et al. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke
    Za Zhi. 201449(1)39-43

9
N staging
  • Increased risk of occult metastasis
  • Tumor thickness / depth of invasion (gt 3 or 4mm)
  • Higher T stage
  • Perineural and angiolymphatic invasion
  • Poor tumor differentiation
  • Yuen et al. Am J Surg. 2000 180 139-143
  • Sparano et al. Otolarngol Head Neck Surg 2004
    131 472-6

10
N staging
  • Incidence of occult neck metastasis
  • T1 16-38
  • T2 21-57
  • T3 77
  • Kaya et al. Am J Otolaryngol 20112259-64
  • Presence of LN mets most important prognostic
    factor
  • Woolgar JA Oral Oncol 26. 42(3) 229-239

11
Current Debates in Neck Management
12
Debates in neck management
Probability of neck metastasis
Complications of neck dissection
Prognostic implications
13
Options for neck management
  • 1. Elective Neck Dissection (END)
  • 2. Watchful waiting
  • 3. Other options
  • Neck irradiation
  • Sentinel LN biopsy

14
Elective neck dissection
  • Which level?
  • 95 metastatic nodes are in ipsilateral levels
    I-III
  • Skip metastasis 16

Liu et al. Oral Oncol 47 (2011) 136-141
Byers et al. Head Neck, 19 (1997) 1419
15
Elective neck dissection
  • Supraomohyoid neck dissection (I-III)
  • Modified radical neck dissection (I-V)

No difference in survival and recurrence
Brazilian Head and Neck Cancer Study Group. Am J
Surg. 1998 Nov176(5)422-7 http//emedicine.medsc
ape.com/article/1894829-overview
16
Options for neck management
  • 1. Prophylactic Elective Neck Dissection (END)
  • 2. Watchful waiting
  • 3. Other options
  • Neck irradiation
  • Sentinel LN biopsy

17
Observation
  • Compliance is crucial
  • MRND for salvage of regional recurrences
  • Many neck recurrences will be of advanced stage
    with poor prognostic factors such as
    extracapsular spread
  • Andersen et al. Am J Surg 1996 172689-691

18
END vs Observation
Authors Duration Country Study population T stage Tumor location Survival Benefit
Vandenbrouck et al (1980) 1966-1973 France 75 T1-3 Oral cavity No
Fakih et al (1989) 1985-1988 India 70 T1-2 Tongue No
Kligerman et al (1994) 1987-1992 Brazil 67 T1-2 Oral cavity Yes
Yuen et al (2009) 1996-2004 Hong Kong 71 T1-2 Tongue No
Vandenbrouck C et al. Cancer 1980 46
386-90 Fakih AR et al. Am J Surg 1989 158
309-313 Kligerman J et al. Am J Surg 1994 168
391-4 Yuen AP et al. Head Neck 2009 31 765-72
19
Prospective randomized study of selective neck
dissection versus observation for N0 neck of
early tongue carcinomaYuen PW, Ho CM, Chow TL,
Tang LC, Wei W et al
  • Outcomes
  • Node related mortality 0
  • Salvage rate 100
  • 5 year Disease specific survival
  • END 89
  • Observation 87
  • (Not statistically significant)

20
A meta-analysis of the RCTs on elective neck
dissection versus therapeutic neck dissection in
oral cavity cancers with clinically node-negative
neckFasunla AJ, Greene BH, Timmesfeld N et al.
21
Do we have the answer yet?
Elective Neck Dissection Observation
Pros Less nodal recurrence Less surgical morbidity than radical or MRND Accurate N staging Avoid unnecessary neck dissection in truly N0 patients
Cons Shoulder morbidities Strict compliance to FU Poor prognostic factors on recurrence
22
Options for neck management
  • 1. Prophylactic Elective Neck Dissection (END)
  • 2. Watchful waiting
  • 3. Other options
  • Neck irradiation
  • Sentinel LN biopsy

23
Irradiation
  • Elective irradiation of the N0 neck produces
    results equivalent to that of neck dissection
  • G.H. Fletcher. Cancer, 29 (1972), pp. 14501454
  • Bataini et al. Eur Arch Otorhinolaryngol, 250
    (1993), 442445
  • Disadvantages
  • No histopathological staging
  • complications of radiation
  • Secondary neoplasms

24
Sentinel LN biopsy
  • Sensitivity 93
  • Negative predictive value 94
  • Upstaging rate 13-60
  • Atula T et al. Eur Arch Otorhinolaryngol.
    2008265 Suppl 1S19-23
  • Tschopp et al. Otolaryngol Head Neck Surg, 132
    (2005), 99102
  • Paleri et al. Head Neck, 27 (2005), 739747
  • Kovacs AF. Surg Oncol Clin N Am 16 (2007), 81-100
  • s

25
Conclusion
  • Management of the N0 neck in stage I and II
    tongue cancer is controversial
  • Main options for management Elective neck
    dissection vs observation
  • Stringent follow up is crucial in detection of
    early nodal metastasis for successful salvage
    surgery
  • Further developments Sentinel LN biopsy

26
The End
27
References
  • http//www.intechopen.com/books/melanoma-from-earl
    y-detection-to-treatment/sentinel-lymph-node-biops
    y-for-melanoma-and-surgical-approach-to-lymph-node
    -metastasi (figure on slide 25)
  • Keski-Santti et al. Sentinel lymph node biopsy or
    elective neck dissection for patients with oral
    squamous cell carcinoma. Eur Arch
    Otorhinolaryngol 2008 265 (suppl) S13-S17
  • Govers et al. Sentinel lymph node biopsy for SCC
    of the oral cavity A diagnostic meta-analysis.
    Oral Oncol 2013 49 726-732
  • Fasunla AJ et al. A meta-analysis of the RCTs on
    elective neck dissection versus therapeutic neck
    dissection in oral cavity cancers with clinically
    node negative neck. Oral Oncol 2011 47 320-324
  • Kovacs AF. Head and neck squamous cell carcinoma
    Sentinel node or selective neck dissection. Surg
    Oncol Clin N Am 2007 16 81-100
  • Fan SF et al. Sentinel lymph node biopsy versus
    elective neck dissection in patients with cT1-2N0
    oral tongue SCC. Oral Pathol Oral Radiol 2014
    117 186-190
  • Melkane AE, et al. Sentinel Node biopsy in early
    oral squamous cell carcinomas A 10 year
    experience. Laryngoscope 2012 122 1782-1788
  • Amaral TMP et al. Predictive factors of occult
    metastasis and prognosis of clinical stages I and
    II squamous cell carcinoma of the tongue and
    floor of mouth. Oral Oncol 2004 40 780-786
  • Yuen APW et al. A comparison of the prognostic
    significance of tumor diameter, length, width,
    thickness, area, volume and clinicopathological
    features of oral tongue carcinoma. Am J Surg
    2000 180 139-143
  • Sparano A et al. Multivariate predictors of
    occult neck metastasis in early oral tongue
    cancers. Otolaryngol Head Neck Surg 2004 131
    472-6
  • Yuen APW et al. Prospective randomized study of
    selective neck dissection versus observation for
    N0 neck of early tongue carcinoma. Head Neck
    2009 31 765-772
  • Kligerman et al. Supraomohyoid neck dissection in
    the treatment of T1/2 squamous cell carcinoma of
    oral cavity. Am J Surg 1994 168 391-4

28
  • Prognostic implications
  • Regional recurrence is the most common cause of
    treatment failure
  • Yuen et al. Head Neck 1997 19583-588
  • Recurrence rate 23.7-42
  • Brugere et al 1996 Khahf et al. 1991 Okamoto et
    al 2002
  • Poor salvage surgery outcomes
  • Accurate N staging (diagnostic limitation)

29
Elective neck dissection
  • Occult metastasis rate gt 20
  • Weiss et al. Arch Otolaryncol Head Neck Surg
    1994, 120(7) 699-702

30
Prognosis
  • 5 year survival relative rate
  • T1 71
  • T2 59
  • T3 47
  • T4 37

American Cancer Society
31
Elective Neck Dissection
  • Which side?
  • Contralateral LN metastasis 4
  • Lim et al. Laryngoscope 2006 116 461-465
  • Higher risk of contralateral neck involvement
  • positive ipsilateral nodes
  • advanced stage primary tumors
  • tumors crossing midline
  • Koo et al. Head Neck. 2006 Oct28(0)896-901
Write a Comment
User Comments (0)
About PowerShow.com